Showing results (561-570 of 763) with videos related to
Sort By:
Pageof 77
Journal of the American College of Cardiology|September 18, 2007
Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT studyAlfred E Buxton, Kerry L Lee, Gail E Hafley, et al.Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|August 21, 2014
Assessment of a fluorescent antibody test for the detection of antibodies against epizootic bovine abortionMyra T Blanchard, Mark L Anderson, Bruce R Hoar, et al.In Vitro Models|February 19, 2026
Gellan Gum-based Bioink for Bioprinting of a Mechanically Mimetic 3D in vitro Liver ModelNatália Akemi Kohori, Ibrahim Fatih Cengiz, Mariana Carvalho, et al.Epidemiology and Psychiatric Sciences|March 29, 2016
Stigma towards people with mental disorders and its components - a perspective from multi-ethnic SingaporeM Subramaniam, E Abdin, L Picco, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Automatic working area classification in peripheral blood smears without cell central zone extractionW Xiong, J H Lim, S H Ong, et al.Psychological Medicine|July 29, 2014
Refining the latent structure of neuropsychological performance in schizophreniaM Lam, S L Collinson, G K Eng, et al.Cancer Biology & Therapy|October 7, 2008
Successful treatment of relapsed lymphomatoid granulomatosis with bexaroteneSigrid E Berg, Lisa H Downs, Drew A Torigian, et al.Journal of Vascular and Interventional Radiology : JVIR|May 8, 2001
Balloon embolization of the internal iliac artery before aneurysm endograft deploymentA Chong, M C Soulen, R A Baum, et al.Journal of Neurochemistry|August 3, 2001
Zn2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cellsS R Seo, S A Chong, S I Lee, et al.Cancer|October 15, 2013
Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomasTahamtan Ahmadi, Elise A Chong, Amanda Gordon, et al.Pageof 77